Front Endocrinol (Lausanne) 12:645566 Zhang Y et al (2022) Network meta-analysis on the effects of finerenone versus SGLT2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease
This is why research groups around the world are trying to engineer microbes to act as edible drug factories
Lancet 402:613626 Fras JP, Davies MJ, Rosenstock J et al (2021) Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
In medical weight loss, hormone balancing, anti-aging and IV therapy
Standard cognitive dose Ideal For Individuals seeking cognitive enhancement, memory improvement, mental clarity optimization, age-related cognitive decline support, or neuroplasticity enhancement under medical guidance
The problem with using EPO directly